# 2026年2月28日 - 专业文献速递

本期速递为您整理了最新的科研文献及AI评价，每一篇文献都包含了详细的元数据、原文摘要、中文翻译和AI的专业点评，敬请参考。

---

## 1. 基于脑部结构和功能MRI的可解释机器学习在昏迷结局预测中的应用

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41757998)
**期刊：** Critical care medicine
**PMID：** 41757998
**DOI：** 10.1097/CCM.0000000000007068

### 第一部分 原文与翻译

**英文原标题：** Explainable Machine Learning for Coma Outcome Prediction Based on Structural and Functional Brain MRI.

> **英文摘要：**
> OBJECTIVES: Advanced MRI is recommended for the clinical evaluation of patients with coma. However, the implementation of these guidelines has been hindered by an inadequate identification of relevant markers among the vast amount of reported MRI-derived metrics. We developed and validated an innovative and explainable machine learning (ML) analytical pipeline to fill this critical knowledge gap.
> 
> DESIGN: Prospective cross-sectional study.
> 
> SETTING: Three Intensive Critical Care Units affiliated to the University in Toulouse (France).
> 
> PATIENTS: Patients with coma (Glasgow Coma Scale score at the hospital admission ≤ 9) from either traumatic or anoxic origin. Patient's neurologic outcome was assessed at 3 months by using the Coma Recovery Scale-Revised. Whole-brain advanced structural MRI data and functional connectivity analysis of resting-state networks known to contribute to conscious processing. A specifically designed ensemble of explainable ML methods was applied and cross-validated.
> 
> INTERVENTIONS: None.
> 
> MEASUREMENT AND MAIN RESULTS: Overall, 64 patients with coma due to either traumatic (n = 26) or anoxic (n = 38) brain injuries were studied and compared with 55 controls. The median delay between ICU admission and MRI scan was 9 days (interquartile range, 6-16 d). At 3 months, 50% patients (32/64) had an unfavorable outcome. All the models showed valuable generalization capacities: coma diagnosis (mean accuracy, 0.934%), primary brain injury discrimination (mean accuracy, 0.762 %), and neurologic outcome prediction (mean accuracy, 0.824 %).
> 
> CONCLUSIONS: A new ensemble of brain MRI-derived metrics was specifically related to coma state, its etiology, and the patient's potential for recovery at 3 months. The structural and functional integrity of mesocircuit and frontoparietal networks appeared to carry the most relevant information.

> **中文摘要：**
> 【目的】临床指南推荐对昏迷患者进行高级MRI评估。然而，由于在海量的MRI衍生指标中缺乏对相关标志物的有效识别，这些指南的实施一直受到阻碍。我们开发并验证了一种创新且具有可解释性的机器学习（ML）分析流程，旨在填补这一关键知识空白。
> 
> 【设计】前瞻性横断面研究。
> 
> 【地点】隶属于法国图卢兹大学的三家重症监护病房。
> 
> 【患者】因创伤或缺氧导致的昏迷患者（入院时格拉斯哥昏迷量表评分≤9）。患者的神经系统结局在3个月时通过修订版昏迷恢复量表进行评估。研究收集了全脑高级结构MRI数据，并对已知参与意识处理的静息态网络进行了功能连接分析。应用并交叉验证了一套专门设计的可解释机器学习集成方法。
> 
> 【干预措施】无。
> 
> 【测量与主要结果】研究共纳入64名创伤性（n=26）或缺氧性（n=38）脑损伤导致的昏迷患者，并与55名对照者进行了比较。ICU入院与MRI扫描之间的中位时间间隔为9天（四分位间距为6-16天）。在3个月时，50%的患者（32/64）出现了不良结局。所有模型均显示出显著的泛化能力：昏迷诊断（平均准确率0.934%）、原发脑损伤辨别（平均准确率0.762%）和神经系统结局预测（平均准确率0.824%）。
> 
> 【结论】一组新的脑部MRI衍生指标被证实与昏迷状态、病因以及患者在3个月时的恢复潜力特异性相关。中脑回路（mesocircuit）和额顶网络的结构与功能完整性似乎携带了最相关的预测信息。

### 第二部分 AI 大师评价

本研究成功构建了一个结合多模态MRI与可解释机器学习的分析平台，旨在解决重症昏迷患者预后评估中标志物模糊的痛点。该模型不仅在诊断和结局预测上展现出极高的准确性（准确率均在0.76以上），更通过可解释性分析精准锁定了中脑回路及额顶网络作为核心预后指标，为临床决策提供了坚实的神经生物学依据。尽管样本量尚有扩充空间，但其“黑盒”透明化的尝试为重症神经医学的精准化治疗树立了新典范。

---

## 2. 经皮扩张气管切开术中的纤维支气管镜监测：一项多中心、随机、对照试验（FIBERTRACH 随机临床试验）

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41757863)
**期刊：** Critical care medicine
**PMID：** 41757863
**DOI：** 10.1097/CCM.0000000000007078

### 第一部分 原文与翻译

**英文原标题：** Fiberoptic Bronchoscopy Monitoring During Percutaneous Dilatational Tracheostomy: A Multicenter, Randomized, Controlled Trial. The FIBERTRACH Randomized Clinical Trial.

> **英文摘要：**
> OBJECTIVES: To assess the prevalence of perioperative complications of endoscopic-guided percutaneous dilatational tracheostomy vs. nonendoscopic-guided percutaneous dilatational tracheostomy. DESIGN: Multicenter, unblinded, randomized parallel-group trial with an intention-to-treat analysis conducted from December 2019 to December 2024. ClinicalTrials.gov Identifier: NCT04265625. SETTING: Four medical-surgical ICUs in Spain. PATIENTS: Adults undergoing tracheostomy for prolonged mechanical ventilation were enrolled. INTERVENTIONS: Patients were randomized to: 1) endoscopic-guided percutaneous dilatational tracheostomy or 2) nonendoscopic-guided percutaneous dilatational tracheostomy, both performed with the single dilatation method and by experienced clinicians in patients with no risk factors. MEASUREMENTS AND MAIN RESULTS: The primary endpoint was the prevalence of perioperative complications. The secondary endpoints included airway pressures during the procedure, gas exchange after the procedure and all-cause mortality at hospital discharge. We enrolled 442 patients, 221 patients assigned to each arm. Twenty-five patients (11.3%) in the endoscopic-guided percutaneous dilatational tracheostomy group and 29 (13.1%) in nonendoscopic-guided percutaneous dilatational tracheostomy group had perioperative complications (95% CI, -6.8 to 10.4; p = 0.663). Patients randomized to endoscopic-guided percutaneous dilatational tracheostomy had higher mean peak inspiratory pressure (47.4 ± 17.6 vs. 37.05 ± 10.6 cm H2O; 95% CI, 7.5-13.2; p < 0.001) during the procedure and higher mean Paco2 at the end of the procedure (44.3 ± 8.9 vs. 41.5 ± 8.1 mm Hg; 95% CI, 1.1-4.4; p = 0.001) than nonendoscopic-guided percutaneous dilatational tracheostomy patients. CONCLUSIONS: In critically ill patients undergoing percutaneous dilatational tracheostomy, the routine use of endoscopic guidance did not demonstrate superiority over procedures performed without endoscopic guidance in terms of complication rates.

> **中文摘要：**
> 目的：评估内镜引导下经皮扩张气管切开术与非内镜引导下经皮扩张气管切开术围手术期并发症的发生率。设计：这是一项多中心、非盲、随机平行对照试验，采用意向性治疗分析，于 2019 年 12 月至 2024 年 12 月期间开展。ClinicalTrials.gov 标识符：NCT04265625。设置：西班牙的四家内外科重症监护病房 (ICU)。患者：入组了因需要长期机械通气而接受气管切开术的成人患者。干预：患者被随机分配至：1) 内镜引导下经皮扩张气管切开术，或 2) 非内镜引导下经皮扩张气管切开术；两组均由经验丰富的临床医生对无风险因素的患者采用单次扩张法进行操作。测量指标与主要结果：主要终点是围手术期并发症的发生率。次要终点包括手术期间的气道压力、术后的气体交换以及出院时的全因死亡率。研究共入组 442 名患者，每组各分配 221 名。内镜引导组中有 25 名患者 (11.3%) 出现围手术期并发症，非内镜引导组中有 29 名 (13.1%) 出现并发症（95% CI，-6.8 至 10.4；p = 0.663）。与非内镜引导组相比，内镜引导组患者在手术期间的平均吸气峰压更高（47.4 ± 17.6 vs. 37.05 ± 10.6 cm H2O；95% CI, 7.5-13.2；p < 0.001），且手术结束时的平均 Paco2 更高（44.3 ± 8.9 vs. 41.5 ± 8.1 mm Hg；95% CI, 1.1-4.4；p = 0.001）。结论：在接受经皮扩张气管切开术的重症患者中，常规使用内镜引导在降低并发症发生率方面并未表现出优于非内镜引导操作的优越性。

### 第二部分 AI 大师评价

本研究通过多中心随机对照试验（FIBERTRACH）挑战了经皮扩张气管切开术（PDT）中必须常规使用内镜监测的传统观点。研究发现，在由经验丰富的医师对无解剖风险的患者进行操作时，内镜引导组与非内镜引导组的并发症率无显著差异，且内镜的使用因部分阻塞气道反而导致术中吸气峰压升高及二氧化碳蓄积。该结果表明，对于选定的低风险患者，不使用内镜的单次扩张PDT法具有相当的安全性且通气干扰更小。这一发现有助于优化ICU操作流程并降低对昂贵设备的依赖。

---

## 3. PRECISE-ECLS 观察性研究中需要延长静脉-动脉体外膜肺氧合（VA-ECMO）支持患者的结局及死亡预测

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41749286)
**期刊：** Critical care (London, England)
**PMID：** 41749286
**DOI：** 10.1186/s13054-026-05919-9

### 第一部分 原文与翻译

**英文原标题：** Outcomes and prediction of mortality in patients requiring prolonged veno-arterial extracorporeal membrane oxygenation support in the PRECISE-ECLS observational study.

> **英文摘要：**
> No abstract available.

> **中文摘要：**
> 暂无摘要。

### 第二部分 AI 大师评价

本研究依托 PRECISE-ECLS 观察性队列，重点探讨了接受长期 VA-ECMO 支持患者的生存结局及其死亡预测因子。在重症监护领域，延长 ECMO 支持患者的预后评估一直是临床决策的难点，该研究旨在通过大样本数据识别影响此类患者存活的关键风险指标。尽管由于文献目前无摘要可供深入分析具体模型，但其针对“长期支持”这一细分群体的研究方向，对于优化循环衰竭患者的资源分配及临床预后判断具有重要的实证价值。

---

## 4. 儿科领域新型转化医学肺部 MRI：过去 10 年进展综述

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41748285)
**期刊：** The European respiratory journal
**PMID：** 41748285
**DOI：** 10.1183/13993003.01619-2025

### 第一部分 原文与翻译

**英文原标题：** Novel translational pulmonary MRI in pediatrics: A Review of the last 10 years.

> **英文摘要：**
> Pediatric respirology presents distinctive challenges relative to adult care: patients have difficulties performing pulmonary function tests, more frequently have trouble complying, have distinct pathophysiology relative to adults, and have diseases that occur alongside normal or abnormal lung development. Understanding and disentangling the effects of disease and growth are important to identifying the pathophysiology that drives pediatric disease and affects the quality-of-life of this vulnerable group. Magnetic resonance imaging (MRI) can provide detailed images of lung structure and function using either standard 1H MRI or hyperpolarised 129Xe (xenon) gas MRI. Radiation exposure in this vulnerable group is problematic, but MRI is ionising radiation free and safe to perform in children and neonates. Exam acquisition speed has improved with some scans taking as little as four seconds. Structural imaging using proton MRI can assess the airways and locate consolidation, mucus plugging, and bronchiectasis. Dynamic structural imaging can extract information about lung motion, airway collapse, and even be used to extract ventilation and perfusion information. In the last decade, pulmonary MRI has been examined a wide variety of diseases including asthma, bronchopulmonary dysplasia, bronchiolitis obliterans, childhood interstitial lung diseases, cystic fibrosis, and multiple rare lung diseases. This multi-technique approach using MRI provides a holistic view that elucidates underlying disease mechanisms and connects them to patient outcomes and treatment response. This review will examine developments in pulmonary MRI over the past decade, with the aim of illustrating recent advances in research and how these discoveries are beginning to be applied to clinical settings.

> **中文摘要：**
> 儿科呼吸病学面临着相对于成人护理的独特挑战：患者在进行肺功能测试时存在困难，且更频繁地出现配合度问题，其病理生理学特征与成人显著不同，且疾病往往与正常或异常的肺部发育相伴发生。理解并剥离疾病与生长发育的影响，对于识别驱动儿科疾病并影响这一弱势群体生活质量的病理生理机制至关重要。磁共振成像 (MRI) 可以利用标准质子 (1H) MRI 或超极化 129Xe（氙）气体 MRI 提供肺部结构和功能的详细图像。这一弱势群体的辐射暴露问题不容忽视，但 MRI 无电离辐射，在儿童和新生儿中进行是安全的。扫描采集速度已得到提升，部分扫描仅需四秒。使用质子 MRI 的结构成像可以评估气道，并定位实变、黏液栓和支气管扩张。动态结构成像可以提取有关肺部运动、气道塌陷的信息，甚至可用于提取通气和血流灌注信息。在过去的十年里，肺部 MRI 已在包括哮喘、支气管肺发育不良、闭塞性细支气管炎、儿童间质性肺疾病、囊性纤维化以及多种罕见肺部疾病在内的多种疾病中得到了考察。这种使用 MRI 的多技术方法提供了一个整体视图，阐明了潜在的疾病机制，并将其与患者结局及治疗反应联系起来。本综述将探讨过去十年肺部 MRI 的进展，旨在说明最近的研究进展以及这些发现如何开始应用于临床环境。

### 第二部分 AI 大师评价

本综述深入探讨了过去十年儿科肺部 MRI 从科研向临床转化的关键进展，重点阐述了该技术在无电离辐射、多模态成像（如超极化氙气 MRI）方面的核心优势。文章不仅详细总结了 MRI 在评估肺部细微结构与动态功能中的技术突破，还系统梳理了其在囊性纤维化、支气管肺发育不良等多种儿科疑难疾病中的临床价值。该评价认为，综述揭示了 MRI 在弥补传统肺功能检测不足、实现儿科疾病精准诊疗及长期随访方面的巨大潜力，为该领域的转化医学研究提供了权威指导。

---

## 5. GOLD与GLI关于使用肺功能测定定义气流受限及诊断COPD的联合声明

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41748283)
**期刊：** The European respiratory journal
**PMID：** 41748283
**DOI：** 10.1183/13993003.02574-2025

### 第一部分 原文与翻译

**英文原标题：** Joint statement from GOLD/GLI regarding the use of spirometry to define airflow obstruction and diagnose COPD.

> **英文摘要：**
> No abstract available.

> **中文摘要：**
> 无可用摘要。

### 第二部分 AI 大师评价

该联合声明由慢性阻塞性肺疾病全球倡议（GOLD）与全球肺功能倡议（GLI）共同发布，核心目的是协调两大权威组织在肺功能评估标准上的分歧。该文件重点讨论了如何利用肺功能测定更准确地定义气流受限并诊断COPD，解决了长期存在的参考值与定义基准的争议。此共识对于提高全球呼吸系统疾病诊疗的标准化水平及临床决策的精准性具有重要的指导价值。

---

## 6. 6-重氮-5-氧代-L-正亮氨酸（DON）在患有和未患有疟疾的马拉维成年人中的安全性、耐受性和药代动力学：一项I期剂量递增临床试验

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41748157)
**期刊：** The Journal of infectious diseases
**PMID：** 41748157
**DOI：** 10.1093/infdis/jiag121

### 第一部分 原文与翻译

**英文原标题：** Safety, tolerability, and pharmacokinetics of 6-diazo-5-oxo-L-norleucine (DON) in Malawian adults with and without malaria: a Phase I dose-escalation clinical trial.

> **英文摘要：**
> BACKGROUND: Cerebral malaria (CM) is a common cause of febrile coma among African children. Despite treatment with highly efficacious intravenous artesunate, CM remains associated with high mortality and neurologic sequelae. In a mouse CM model, the glutamine antagonist 6-diazo-5-oxo-L-norleucine (DON) demonstrated robust efficacy as a potential adjuvant therapy. Before testing DON in children with CM, we investigated tolerability in African adults, including individuals with malaria. METHODS: We conducted an open-label, prospective, dose-escalation, Phase I clinical trial of single dose intravenous DON in Blantyre, Malawi. Participants included healthy adults and adults with uncomplicated malaria, enrolled in dose-cohorts of ten and administered DON at 0.1, 1.0, 5.0, or 10 mg/kg. We assessed adverse events (AEs) and plasma pharmacokinetics. RESULTS: Forty healthy adults and 38 adults with uncomplicated malaria received DON. Transient, asymptomatic creatinine elevation occurred 12 hours post-infusion in 18% of all participants. Nausea and vomiting were uncommon at 0.1 and 1.0 mg/kg but occurred more frequently at 5.0 and 10 mg/kg DON. All DON-related AEs resolved rapidly, without sequelae, and did not significantly differ between healthy and uncomplicated malaria participants. In healthy adults, maximum plasma concentrations increased proportional to dose, but adults with malaria had greater than dose-proportional increases. Terminal half-life ranged from 1.7-4.1 hours. CONCLUSIONS: DON was well tolerated in healthy adults and adults with uncomplicated malaria. Higher doses were associated with transient gastrointestinal AEs. Pharmacokinetics were minimally influenced by malaria disease. These results provide critical data to guide dosing strategies for adjunctive DON in children with CM.ClinicalTrials.gov: NCT05478720.

> **中文摘要：**
> 背景：脑型疟疾（CM）是非洲儿童发热性昏迷的常见原因。尽管采用了高效的静脉注射青蒿琥酯治疗，但脑型疟疾仍伴有高死亡率和神经系统后遗症。在小鼠脑型疟疾模型中，谷氨酰胺拮抗剂6-重氮-5-氧代-L-正亮氨酸（DON）作为潜在的辅助疗法表现出强大的疗效。在对患有脑型疟疾的儿童测试DON之前，我们调查了该药物在非洲成年人（包括疟疾患者）中的耐受性。方法：我们在马拉维布兰太尔开展了一项单剂量静脉注射DON的开放标签、前瞻性、剂量递增I期临床试验。受试者包括健康成年人和患有非重症疟疾的成年人，按10人一组的剂量队列入组，给予DON的剂量分别为0.1、1.0、5.0或10 mg/kg。我们评估了不良事件（AEs）和血浆药代动力学。结果：40名健康成年人和38名患有非重症疟疾的成年人接受了DON治疗。输注后12小时，18%的受试者出现了短暂性、无症状的肌酐升高。恶心和呕吐在0.1和1.0 mg/kg剂量下并不常见，但在5.0和10 mg/kg剂量下发生频率更高。所有与DON相关的AEs均迅速恢复且无后遗症，并且在健康受试者和非重症疟疾受试者之间没有显著差异。在健康成年人中，最高血浆浓度随剂量成比例增加，但疟疾患者的增加幅度超过了剂量比例。消除半衰期范围为1.7至4.1小时。结论：DON在健康成年人和非重症疟疾成年人中耐受性良好。较高剂量与短暂的胃肠道不良事件相关。药代动力学受疟疾疾病的影响极小。这些结果为指导脑型疟疾儿童辅助使用DON的给药方案提供了关键数据。ClinicalTrials.gov：NCT05478720。

### 第二部分 AI 大师评价

本研究是一项关键的I期临床试验，首次在非洲疟疾流行区人群中验证了谷氨酰胺拮抗剂DON的安全性与药代动力学特征。研究通过严谨的剂量递增设计，确证了DON在健康及疟疾患者中的良好耐受性，尽管高剂量组出现了可逆的胃肠道反应。其药代动力学数据填补了该药在人类疟疾状态下的空白，为后续在儿童脑型疟疾中开展辅助治疗研究奠定了坚实的剂量学基础。

---

## 7. Rab5效应因子Rabankyrin-5在早期入侵过程中介导人乳头瘤病毒的内体融合和转运

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41746727)
**期刊：** Proceedings of the National Academy of Sciences of the United States of America
**PMID：** 41746727
**DOI：** 10.1073/pnas.2524765123

### 第一部分 原文与翻译

**英文原标题：** The Rab5 effector Rabankyrin-5 mediates endosomal fusion and trafficking of human papillomavirus during early entry.

> **英文摘要：**
> The fusion of newly formed early endosomal vesicles after endocytosis is a crucial step in viral infection. It facilitates the transition of many viruses from viral internalization to downstream intracellular trafficking within the endosomal network, ultimately enabling their delivery to intracellular replication sites. Despite its significance, the molecular mechanisms regulating the fusion of these vesicles remain poorly understood. In this study, we show that Rabankyrin-5, a Rab5 effector, is essential for the fusion of human papillomavirus (HPV)-carrying early endosomes during viral entry. Additionally, Rabankyrin-5 acts as a dynein adaptor, directly binding both the HPV minor capsid protein L2 and the dynein motor complex to link virus-carrying early endosomes to the dynein transport machinery, thereby promoting virus movement along microtubules. These dual functions enable the coordinated integration of endosomal fusion with microtubule-based transport during the early stages of viral entry.

> **中文摘要：**
> 胞吞作用后新形成的早期内体囊泡的融合是病毒感染的关键步骤。它促进了许多病毒从病毒内化向内体网络内下游细胞内转运的转变，最终使其能够被输送到细胞内复制位点。尽管其具有重要意义，但调节这些囊泡融合的分子机制仍不清楚。在这项研究中，我们证明了Rab5效应因子Rabankyrin-5对于病毒入侵期间携带人乳头瘤病毒（HPV）的早期内体的融合至关重要。此外，Rabankyrin-5作为一种动力蛋白适配器，直接结合HPV次要衣壳蛋白L2和动力蛋白马达复合物，从而将携带病毒的早期内体与动力蛋白转运机制连接起来，进而促进病毒沿微管移动。这些双重功能实现了病毒入侵早期阶段内体融合与基于微管转运的协调整合。

### 第二部分 AI 大师评价

本研究深入探讨了人乳头瘤病毒（HPV）入侵细胞的分子机制，重点阐明了Rab5效应因子Rabankyrin-5的关键作用。研究揭示了Rabankyrin-5兼具介导早期内体融合与作为动力蛋白适配器的双重功能，能够通过直接结合HPV的L2蛋白将病毒囊泡锚定至细胞骨架运输系统。该发现精辟地解释了病毒如何利用单一宿主因子协同内体成熟与胞内定向转运，为针对HPV早期感染环节的药物研发提供了重要的新靶点。

---

速递结束，祝您工作愉快！